Zydus Lifesciences Limited

Zydus Lifesciences Limited

Zydus Lifesciences Limited has announced disclosures under SEBI (Prohibition of Insider Trading) Regulations regarding its recent share buyback program. The announcement details the acceptance of equity shares tendered by promoters, promoter group, directors, and their immediate relatives through a proportionate tender offer. Notably, Zydus Family Trust, a key promoter, had 63,49,542 equity shares accepted in the buyback. Post-buyback, the Trust's holding percentage slightly increased from 74.96% to 74.98%. This signifies strong promoter participation and their continued significant stake in the company following the tender offer.

Zydus Lifesciences Limited

Zydus Lifesciences Limited announced the extinguishment of 8,730,158 fully paid-up equity shares following a share buyback. These shares, with a face value of INR 1 each, were bought back at a price of INR 1,260 per share through a tender offer route. The aggregate amount for this buyback totalled INR 1,100 crore. This action reduces the company's outstanding share capital, which can potentially enhance earnings per share (EPS) and shareholder value for the remaining investors.

Zydus Lifesciences Limited

Zydus Lifesciences Limited has submitted a copy of the post buyback public advertisement pertaining to the buyback of up to 87,30,158 equity shares at INR 1,260 per share for an aggregate amount not exceeding INR 1100,00,00,000.